3Crabb DW. Alcoholic liver disease: New concepts in pathogenesis. In: Sucky FJ, Fitz JG, Maher JJ,eds. Mechanisms of acute and chronic liver diseases: Implication for diagnosis, pathogenesis and treatment. Postgraduate Course Boston: AASLD,2002. 104-112.
4Hall P de la M. Alcoholic liver disease. In: MacSween RN, Anthony PP, Scheuer PJ, Burt AC,Portmann BC, eds. Pathology of the liver. 4th, ed.London: Churchill Livingstone, 2002. 273-311.
5Goodman ZD. Role of pathology m management of fatty liver disease. In: Sucky FJ, Fitz JG, Maher JJ, eds. Mechanisms of acute and chronic liver diseases: Implication for diagnosis, pathogenesis and treatment. Postgraduate Course Boston: AASLD, 2002. 127-133.
6Stumptner C, Fuchsbichler A, Heid H, Zatloukal K, Denk H. Mallory body - a disease-associated type of sequestosome. Hepatology, 2002, 35: 1053~1062.
7French SW, Nash J, Shitabata P, Kachi K, Hara C, Chedid A, Mendenhall CL. Pathology of alcoholic liver disease. VA Cooperative Study Group 119. Semin Liver Dis, 1993, 13: 154-169.
8Savolainen VT, Lalu K, Penttila A, Virtanen I,Karhunen PJ. Cytokeratin inclusions in alcoholic liver disease and their relation to the amount of alcohol intake. Liver, 1994, 14: 281-287.
9Worner TM, Lieber CS. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA, 1985, 254:627 -630.
10Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet, 1995,346: 987-990.
